A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Duloxetine and Methadone for the Treatment of HIV-Associated Painful Peripheral Neuropathy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Duloxetine (Primary) ; Methadone (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
Most Recent Events
- 18 Feb 2019 Biomarkers information updated
- 29 Oct 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 24 Apr 2012 Actual patient number is 15 according to ClinicalTrials.gov.